Keyphrases
Patients with Colorectal Cancer
100%
Vaccination
100%
Cell-based
100%
Blood Levels
100%
Stable Disease
75%
Tumor Necrosis Factor-α
50%
Tissue Inhibitor of metalloproteinase-1 (TIMP-1)
50%
Interleukin-5 (IL-5)
50%
Interleukin-2
50%
Th1 Response
50%
Granulocyte Colony-stimulating Factor (G-CSF)
50%
Interleukin-8
25%
Interleukin-6
25%
Inflammatory Cytokines
25%
Interleukin-1β
25%
Cytokine Response
25%
Therapeutic Potential
25%
Interleukin-10
25%
Progressive Disease
25%
Interferon-γ
25%
Serum Samples
25%
In Cancer
25%
Cancer Treatment
25%
Dendritic Cells
25%
Plasma Samples
25%
Melanoma Cells
25%
Immunological Mechanisms
25%
Interleukin-12 (IL-12)
25%
Allogeneic
25%
Treatment Optimization
25%
MIP-1b
25%
Cancer Vaccine
25%
Vaccine Response
25%
Cancer Immunotherapy
25%
Dendritic Cell Vaccine
25%
IFN-γ/IL-4
25%
Luminex
25%
IP-10
25%
Intensive Monitoring
25%
Cell Lysate
25%
Biomarker Response
25%
Multiplex Assay
25%
Eotaxin
25%
Immunology and Microbiology
Blood Level
100%
Cytokine
100%
Vaccination Policy
100%
Dendritic Cell
100%
Blood Plasma
40%
Tumor Necrosis Factor Alpha
40%
Carcinoembryonic Antigen
40%
Vaccine Efficacy
40%
Granulocyte Macrophage Colony-Stimulating Factor
40%
Proinflammatory Cytokine
20%
Interleukin-6
20%
ELISA
20%
Immunotherapy
20%
Cancer Vaccine
20%
Cell Lysate
20%
Melanoma Cell
20%
Cancer Immunotherapy
20%
Eotaxin
20%